Benign prostatic hyperplasia: maximizing treatment with alpha blockers
Lowenthal, D.T.; Flannery, M.; Mader, S.L.; Nelson, R.P.
Geriatrics 53(Suppl 2): S4-28
1998
ISSN/ISBN: 0016-867X PMID: 9789482 Document Number: 484112
Document emailed within 1 workday
Related Documents
Lepor, H. 1995: Alpha blockade for the treatment of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 375-386Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133
Djavan, B.; McConnell, J. 1996: The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 165-168
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Sun, Z.Y.; Tu, Z.H. 1998: A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia Methods and Findings in Experimental and Clinical Pharmacology 20(4): 283-287
Gao, W.-J.; Wang, Y.-M.; Wang, C.-H.; Yang, X.-K.; Wan, L.; Li, W.-P. 2013: Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications Zhonghua Nan Ke Xue 19(4): 315-320
Matsumoto, S.; Uemura, H. 2008: Examination of the mechanism of ameliorating effect of alpha 1-blocker on storage symptoms associated with benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 54(6): 453-456
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Denti, L.; Pasolini, G.; Cortellini, P.; Sanfelici, L.; Benedetti, R.; Cecchetti, A.; Ferretti, S.; Banchini, A.; Ablondi, F.; Valenti, G. 1999: Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH) Journal of Endocrinological Investigation 22(10 Suppl): 70-71
McConnell, J.D. 1995: Benign prostatic hyperplasia. Hormonal treatment Urologic Clinics of North America 22(2): 387-400
Ekman, P.; Andersen, J.T.; Wolf, H. 1996: Finasteride in the treatment of benign prostatic hyperplasia Acta Urologica Belgica 64(1): IX-XII
Kumanov, H.; Mladenov, D.; Nikolov, S.; Penkov, R.; Stratev, S.; Kotzev, R.; Petkova, L.; Ganev, T.; Uzunov, A.; Uzunov, N. 1998: Treatment of benign prostatic hyperplasia with tamsulosin Khirurgiia 53(6): 38-41
Gorilovskiĭ, L.M. 1995: Permixon in the treatment of benign prostatic hyperplasia Terapevticheskii Arkhiv 67(8): 62-64
Ustinov, D.V.; Kholtobin, D.P.; Kul'chavenia, E.V.; Aĭzikovich, B.I. 2013: The use of laser vaporization for the treatment of benign prostatic hyperplasia Urologiia 4: 74
Chepurov, A.K. 1999: Holmium laser treatment of benign prostatic hyperplasia Urologiia 4: 39-41
Moon, L.; Pfettscher, S. 1995: Hytrin treatment of hypertension and benign prostatic hyperplasia Anna Journal 22(3): 335-336
Song, Y.; Li, N.-c.; Wang, X.-f.; Ma, L.-l.; Wan, B.; Hong, B.-f.; Na, Y.-q. 2005: Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia Zhonghua Nan Ke Xue 11(9): 674-676
Schlatmann, T.J. 1992: Benign prostatic hyperplasia; recommendations for diagnosis and treatment in 1992 Nederlands Tijdschrift Voor Geneeskunde 136(49): 2414-2417
Wu, T.T.; Lee, Y.H.; Jiaan, B.P.; Huang, J.K. 1995: The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia Zhonghua Yi Xue Za Zhi 56(6): 399-403